New calibration now available plus standards and controls now Ready to use

Immundiagnostik AG, manufacturer of the lDKmonitor® lnfliximab drug level ELISA (K9655), have recalibrated the assay in accordance with the WHO standard material WHO infliximab standard (NlBSC, product #16/170). The recalibrated kit is available to order now and existing customers will be contacted about the change. To coincide with the recalibration, the kit calibrators and controls will switch from lyophilized to more convenient ready-to-use standards and controls. You can read more about the new NIBSC standard for Infliximab here: https://www.nibsc.org/documents/ifu/16-170.pdf If you have any questions about the assay please contact Customer Services on +44 151 550 4 550 or cs@biohithealthcare.co.uk and we will be happy to assist you.